Member Theresa Carnegie shared insights in a Law360 Healthcare Authority article about a federal government bulletin stating that drug manufacturers will be able to sell medications directly to patients through TrumpRx, without violating federal anti-kickback laws. The article sheds light on the potential legal risks associated with excluding telehealth providers, pharmacies, and other parties not covered by the bulletin.

Theresa says, "There are a lot of financial interrelationships that have to happen in order to get the drugs actually in the patient's hands, those pieces, I think, are unclear and still have to be analyzed from a fraud and abuse perspective."

Source

Law360 Healthcare Authority